Table: AnGes MG -2016 group forecast
Dec 6 (Reuters) -
AnGes MG Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2016 Dec 31, 2016
LATEST PREVIOUS
FORECAST FORECAST
Sales 500 mln 400 mln
Operating loss 5.20 loss 6.40
Recurring loss 5.20 loss 6.40
Net loss 5.20 loss 6.40
EPS loss 81.96 yen loss 100.88 yen
NOTE - AnGes MG Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4563.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on AnGes
See all newsTable: Anges -Q1 group results
Brief: Vasomune Therapeutics, Inc., And Anges, Inc., Announce Us FDA Clearance Of Investigational New Drug (Ind) Application For Pegevongitide (Av-001) Treatment In Resuscitation Of Severely Burned Patients
Table: Anges -2025 parent results
Table: Anges -2025 group results
Brief: Anges & Vasomune Therapeutics Enter Agreement For AV-001